Form 4: Enanta Pharmaceuticals Executive Forfeits Shares to Cover Taxes

Tara Lynn Kieffer, Chief Product Strategy Officer at Enanta Pharmaceuticals, forfeited 753 shares of common stock to cover withholding taxes related to a restricted stock unit award.

Summary

• Tara Lynn Kieffer, Chief Product Strategy Officer at Enanta Pharmaceuticals, forfeited 753 shares of common stock on December 1, 2024.
• The shares were forfeited to cover withholding taxes due from the settlement of a portion of a restricted stock unit award granted on November 19, 2021.
• Following the transaction, Ms. Kieffer directly owns 31,588 shares of Enanta Pharmaceuticals common stock.

Sentiment

Score: 5

Explanation: This is a neutral event related to standard executive compensation practices and does not indicate any positive or negative sentiment.

Industry Context

This is a routine transaction related to executive compensation and tax obligations, common in publicly traded companies.

Comparison to Industry Standards

• Stock forfeitures to cover tax obligations are a standard practice in the industry for executives receiving equity-based compensation.
• Many companies use restricted stock units as part of their compensation packages, and the tax implications are typically handled through share forfeitures or sales.

Stakeholder Impact

• The transaction has a minimal impact on shareholders as it is a standard procedure for executive compensation.

Key Dates

Keywords

Enanta Pharmaceuticals, stock forfeiture, insider trading, restricted stock unit, tax withholding, executive compensation